Skip to main content

Find Clinical Trials

Home
Conditions
HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors

Clinical trial condition

HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors

Explore clinical trials studying HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors trial results

Not Yet Recruiting

SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors

NCT06516926

Conditions: HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details